Association of polyphenol biomarkers with cardiovascular disease and mortality risk: A systematic review and Meta-Analysis of observational studies

Nutrients

Volumn 9, Issue 4, 2017, Pages

  Rienks, Johanna ^a   Barbaresko, Janett ^a   Nöthlings, Ute ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Biomarkers; Cardiovascular disease; Enterolactone; Flavonoids; Meta analysis; Mortality; Observational; Polyphenols

Indexed keywords

APIGENIN; ENTERODIOL; ENTEROLACTONE; FLAVONOID; HESPERETIN; ISORHAMNETIN; KAEMPFEROL; LIGNAN; NARINGENIN; PHLORETIN; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL; TAMARIXETIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; POLYPHENOL;

ACUTE CORONARY SYNDROME; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; META ANALYSIS; METABOLITE; MORTALITY RISK; REVIEW; SYSTEMATIC REVIEW; URINALYSIS; ANIMAL; CHEMISTRY; FOOD ANALYSIS; METABOLISM; MORTALITY;

ANIMALS; BIOMARKERS; CARDIOVASCULAR DISEASES; FOOD ANALYSIS; HUMANS; POLYPHENOLS;

EID: 85018285595     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9040415     Document Type: Review

References (36)

1. World Health Organisation (WHO). Cardiovascular Diseases (CVDs). Available online: http://www.who. int/mediacentre/factsheets/fs317/en/ (accessed on 6 January 2017).
2. Neveu, V., Perez-Jimenez, J., Vos, F., Crespy, V., du Chaffaut, L., Mennen, L., Knox, C., Eisner, R., Cruz, J., Wishart, D., et al. Phenol-explorer: An online comprehensive database on polyphenol contents in foods. Database: J. Biol. Databases Curation 2010, 2010, bap024.
3. Spencer, J.P., Abd El Mohsen, M.M., Minihane, A.M., Mathers, J.C. Biomarkers of the intake of dietary polyphenols: Strengths, limitations and application in nutrition research. Br. J. Nutr. 2008, 99, 12-22.
4. Manach, C., Williamson, G., Morand, C., Scalbert, A., Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S-242S.
5. Manach, C., Scalbert, A., Morand, C., Remesy, C., Jimenez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
6. Landete, J.M. Updated knowledge about polyphenols: Functions, bioavailability, metabolism, and health. Crit. Rev. Food Sci. Nutr. 2011, 52, 936-948.
7. Erdman, J.W., Jr., Balentine, D., Arab, L., Beecher, G., Dwyer, J.T., Folts, J., Harnly, J., Hollman, P., Keen, C.L., Mazza, G., et al. Flavonoids and heart health: Proceedings of the ilsi north america flavonoids workshop, May 31-June 1, 2005, Washington, DC. J. Nutr. 2007, 137, 718S-737S.
8. Crozier, A., Jaganath, I.B., Clifford, M.N. Dietary phenolics: Chemistry, bioavailability and effects on health. Nat. Prod. Rep. 2009, 26, 1001-1043.
9. Bhagwat, S., Haytowitz, D.B., Wasswa-Kintu, S.I., Holden, J.M. USDA develops a database for flavonoids to assess dietary intakes. Procedia Food Sci. 2013, 2, 81-86.
10. Linseisen, J., Rohrmann, S. Biomarkers of dietary intake of flavonoids and phenolic acids for studying diet-cancer relationship in humans. Eur. J. Nutr. 2008, 47, 60-68.
11. Zamora-Ros, R., Rabassa, M., Cherubini, A., Urpi-Sarda, M., Llorach, R., Bandinelli, S., Ferrucci, L., Andres-Lacueva, C. Comparison of 24-h volume and creatinine-corrected total urinary polyphenol as a biomarker of total dietary polyphenols in the invecchiare inchianti study. Anal. Chim. Acta 2011, 704, 110-115.
12. Rienks, J., Barbaresko, J., Nöthlings, U. Association of isoflavone biomarkers with chronic disease and mortality risk: A systematic literature review and meta-analysis of observational studies. Nutr. Rev. 2017. accepted.
13. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P. Preferred reporting items for systematic reviews and meta-analyses: The prisma statement. PLoS Med. 2009, 6, e1000097.
14. Wells, G.A., Shea, B., O’Connell, D., Peterson, J., Welch, V., Tugwell, P. The Newcastle-Ottawa Scale (nos) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online: http://www.ohri.ca/ programs/clinical_epidemiology/oxford.asp (accessed on 1 July 2015).
15. Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G. Measuring inconsistency in meta-analyses. BMJ (Clin. Res. Ed.) 2003, 327, 557-560.
16. DerSimonian, R., Laird, N. Meta-analysis in clinical trials. Controlled Clin. Trials 1986, 7, 177-188.
17. Egger, M., Davey Smith, G., Schneider, M., Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin. Res. Ed.) 1997, 315, 629-634.
18. Schwarzer, G. Meta: General Package for Meta-Analysis. R Package Version 4.3-2. Available online: http://CRAN.R-project.org/package=meta (accessed on 17 February 2015).
19. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria. Available online: http://www.R-project.org/ (accessed on 1 January 2014).
20. Bredsdorff, L., Obel, T., Dethlefsen, C., Tjonneland, A., Schmidt, E.B., Rasmussen, S.E., Overvad, K. Urinary flavonoid excretion and risk of acute coronary syndrome in a nested case-control study. Am. J. Clin. Nutr. 2013, 98, 209-216.
21. Kilkkinen, A., Erlund, I., Virtanen, M.J., Alfthan, G., Ariniemi, K., Virtamo, J. Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of finnish male smokers. Am. J. Epidemiol. 2006, 163, 687-693.
22. Kuijsten, A., Bueno-de-Mesquita, H.B., Boer, J.M.A., Arts, I.C.W., Kok, F.J., van’t Veer, P., Hollman, P.C.H. Plasma enterolignans are not associated with nonfatal myocardial infarction risk. Atherosclerosis 2009, 203, 145-152.
23. Reger, M.K., Zollinger, T.W., Liu, Z., Jones, J., Zhang, J. Urinary phytoestrogens and cancer, cardiovascular, and all-cause mortality in the continuous national health and nutrition examination survey. Eur. J. Nutr. 2016, 55, 1029-1040.
24. Vanharanta, M., Voutilainen, S., Lakka, T.A., van der Lee, M., Adlercreutz, H., Salonen, J.T. Risk of acute coronary events according to serum concentrations of enterolactone: A prospective population-based case-control study. Lancet 1999, 354, 2112-2115.
25. Vanharanta, M., Voutilainen, S., Rissanen, T.H., Adlercreutz, H., Salonen, J.T. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio ischaemic heart disease risk factor study. Arch. Intern Med. 2003, 163, 1099-1104.
26. Zamora-Ros, R., Rabassa, M., Cherubini, A., Urpi-Sarda, M., Bandinelli, S., Ferrucci, L., Andres-Lacueva, C. High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults. J. Nutr. 2013, 143, 1445-1450.
27. Semba, R.D., Ferrucci, L., Bartali, B., Urpi-Sarda, M., Zamora-Ros, R., Sun, K., Cherubini, A., Bandinelli, S., Andres-Lacueva, C. Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern. Med. 2014, 174, 1077-1084.
28. Tresserra-Rimbau, A., Rimm, E.B., Medina-Remon, A., Martinez-Gonzalez, M.A., Lopez-Sabater, M.C., Covas, M.I., Corella, D., Salas-Salvado, J., Gomez-Gracia, E., Lapetra, J., et al. Polyphenol intake and mortality risk: A re-analysis of the predimed trial. BMC Med. 2014, 12, 77.
29. Milder, I.E., Feskens, E.J., Arts, I.C., Bueno-de-Mesquita, H.B., Hollman, P.C., Kromhout, D. Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the zutphen elderly study. Am. J. Clin. Nutr. 2006, 84, 400-405.
30. Van der Schouw, Y.T., Kreijkamp-Kaspers, S., Peeters, P.H.M., Keinan-Boker, L., Rimm, E.B., Grobbee, D.E. Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in western women. Circulation 2005, 111, 465-471.
31. Wang, X., Ouyang, Y.Y., Liu, J., Zhao, G. Flavonoid intake and risk of CVD: A systematic review and meta-analysis of prospective cohort studies. Br. J. Nutr. 2014, 111, 1-11.
32. Ponzo, V., Goitre, I., Fadda, M., Gambino, R., De Francesco, A., Soldati, L., Gentile, L., Magistroni, P., Cassader, M., Bo, S. Dietary flavonoid intake and cardiovascular risk: A population-based cohort study. J. Transl. Med. 2015, 13, 218.
33. Jacques, P.F., Cassidy, A., Rogers, G., Peterson, J.J., Dwyer, J.T. Dietary flavonoid intakes and cvd incidence in the framingham offspring cohort. Br. J. Nutr. 2015, 114, 1496-1503.
34. Tresserra-Rimbau, A., Rimm, E.B., Medina-Remon, A., Martinez-Gonzalez, M.A., de la Torre, R., Corella, D., Salas-Salvado, J., Gomez-Gracia, E., Lapetra, J., Aros, F., et al. Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the predimed study. Nutr. Metab. Cardiovasc. Dis. (NMCD) 2014, 24, 639-647.
35. Kilkkinen, A., Pietinen, P., Klaukka, T., Virtamo, J., Korhonen, P., Adlercreutz, H. Use of oral antimicrobials decreases serum enterolactone concentration. Am. J. Epidemiol. 2002, 155, 472-477.
36. Potischman, N., Freudenheim, J.L. Biomarkers of nutritional exposure and nutritional status: An overview. J. Nutr. 2003, 133, 873S-874S.